r/pharmaindustry

Most people who followed $CYDY remember March 30, 2021. The FDA publicly stated that CytoDyn's claims about leronlimab were "misleading and not supported by the data", no benefit was shown in COVID-19 treatment trials. The stock dropped 25%+ that day.

What happened afterward was a class action lawsuit covering investors who held $CYDY between March 27, 2020 and March 30, 2022.

A $500,000 settlement has been reached and terms are now submitted to the court for approval.

Who qualifies?

Anyone who held $CYDY during the class period and suffered losses from the alleged misrepresentations about leronlimab's effectiveness for HIV and COVID-19.

Can I still apply?

Yes, you can submit your application now and it will be processed once claims filing officially opens after court approval.

If you were damaged by this don't forget to check your eligibility. GL!

I'm a PharmD currently working in a market access marketing manager role (3 YOE) at a life science consultancy supporting 1 client account working across several products in multiple therapeutic areas.

I recently received an offer to move into an in-house role (adjacent role/title) at a small biopharma that has 1 commercial product in onc.

The offer is roughly 20% higher than my current base, but there's been discussion of me getting a raise followed by a mid-year promo at my current role. The consultancy has gone through multiple RIFs in the past year, but I believe my role is relatively safe.

I rather like my current role and team, but my primary career goals at the moment are to:

Continue building strong market access experience
Eventually move into a strategy role
Maximize long-term earning potential

Some questions I have considered:

Is now the right time to move to the manufacturer side, or would it be better to stay in consulting longer and reach AD level first?
How valuable is manufacturer-side experience compared with consulting experience when pursuing strategy roles?
Would moving from supporting 7 products to only 1 product be viewed as a step forward or backward from a career development perspective?

Thank you!

r/pharmaindustry

Moving from agency to in-house role